BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Drug Development

  Vical and Mycoses Study Group Education and Research Consortium Establish Collaboration to Advance Vical’s Novel Antifungal VL-2397 for the Treatment of Invasive Aspergillosis

  This collaboration will combine the clinical development expertise of Vical with the specialized expertise of the MSGERC in the area of invasive fungal infections.

  February 1, 2018

   · 

  4 min read
• BioMidwest

  SAB Capra Awarded $225K from NIH to Broaden Novel Immunotherapy Platform

  The company will use the funds, awarded through the National Institute of Allergy and Infectious Disease (NIAID), to continue development and optimization of its transchromosomal (Tc) goats to broaden the Tc animal platform developed by SAB Biotherapeutics, to small ungulate species.

  February 1, 2018

   · 

  3 min read
• Business

  Sensus Healthcare Reports Record Revenue for 2017 Fourth Quarter and Full Year

  Sensus Healthcare announces financial results for the three and 12 months ended December 31, 2017.

  February 1, 2018

   · 

  26 min read
• Business

  Amgen Reports Fourth Quarter and Full Year 2017 Financial Results

  For the fourth quarter, total revenues decreased 3 percent versus the fourth quarter of 2016 to $5.8 billion.

  February 1, 2018

   · 

  61 min read
• Business

  Varex Imaging Announces Financial Results for First Quarter of Fiscal Year 2018

  Varex Imaging today announced its financial results for the first quarter of fiscal year 2018.

  February 1, 2018

   · 

  25 min read
• Biotech Beach

  Viking Announces Proposed Public Offering of Common Stock

  Viking today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

  February 1, 2018

   · 

  5 min read
• Business

  Edwards Lifesciences Corp. Reports Fourth Quarter Results

  Edwards Lifesciences, today reported financial results for the quarter ended December 31, 2017.

  February 1, 2018

   · 

  49 min read
• Business

  Aethlon Medical Announces Fiscal 2018 Third Quarter Results

  Aethlon Medical today announced results for its fiscal third quarter ended December 31, 2017.

  February 1, 2018

   · 

  19 min read
• Drug Development

  AnaBios Release: Frontiers in Physiology Publishes Research Showing Pro-Arrhythmia Risk Predictivity of Adult Human Primary Ventricular Tissue-Based Model

  For this research, human ventricular trabeculae isolated from ethically-consented organ donors were used to assess the effects of 13 blinded clinical reference drugs on cardiac action potential.

  February 1, 2018

   · 

  2 min read
• Biotech Bay

  Pivotal SAKURA Phase II Clinical Data to be Presented at IMCAS World Congress 2018

  Revance announced presentation of clinical data from the company’s two pivotal SAKURA Phase 3 trials of DaxibotulinumtoxinA Injectable (RT002) at the 20th annual IMCAS (International Master Course on Aging Skin) World Congress, taking place at Palais des Congrès, Paris, France, February 1-3, 2018.

  February 1, 2018

   · 

  4 min read